🇦🇺 Australia Country × Condition
metastatic breast cancer Clinical Trials in Australia
Active clinical trials for metastatic breast cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 3, Phase 1 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Enrollment
540 pts
Country
🇦🇺 Australia
Relay Therapeutics, Inc.
View Trial → NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Enrollment
1,000 pts
Country
🇦🇺 Australia
Olema Pharmaceuticals, Inc.
View Trial → NCT05508906 Phase 1
Recruiting
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Enrollment
190 pts
Country
🇦🇺 Australia
Olema Pharmaceuticals, Inc.
View Trial → NCT03424005 Phase 1, Phase 2
Recruiting
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Enrollment
1,132 pts
Country
🇦🇺 Australia
Hoffmann-La Roche
View Trial → Frequently Asked Questions
How many metastatic breast cancer clinical trials are active in Australia?
There are currently 4 active clinical trials for metastatic breast cancer with sites in Australia, of which 4 are actively recruiting patients.
How can I join a metastatic breast cancer clinical trial in Australia?
To join a metastatic breast cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are metastatic breast cancer trials in Australia?
Active metastatic breast cancer trials in Australia span Phase 3, Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology